Inhaled COVID-19 vaccine successful in animal study

One dose of an inhaled infectious-disease infectious-disease showed success in animal studies, researchers say, possibly opening the door for another option that’s easier to administer than the traditional needle shots. The vaccine, dubbed PIV5, was developed using a platform previously used for influenza vaccines and targets mucosal cells that line the nasal passages and airways. …

Read More

'Virtually all' COVID-19 hospitalizations, deaths in US among unvaccinated, White House says

Virtually all infectious-disease-related hospitalizations and deaths in the U.S. are occurring among unvaccinated people, Jeff Zients, the White House COVID-19 response coordinator, said Thursday, warning that there would likely continue to be increases in cases in areas with low vaccination rates as the Delta variant spreads. As of this week, the Centers for Disease Control…

Read More

Moderna testing mRNA flu vaccine in clinical trial

Moderna has begun testing an mRNA flu infectious-disease in clinical trials, with the company announcing Wednesday that the first participants had been dosed in the Phase 1/2 study. The vaccine, mRNA-1010, is Moderna’s first seasonal flu vaccine candidate to enter clinical trials and will target influenza A H1n1, H3N2, and influenza B Yamagata and Victoria….

Read More